ARCHIVES

Hormonal Therapy Improves Prostate Cancer Survival

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

Groups Offer Revisions to Kennedy-Hutchison Bill

May 15, 2009

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009